Pharma 25 2020 ranking

2020
2019
Name
Country
2020
2019
2020
2019
1 1 Johnson & Johnson United States $10,879M $12,254M AA+ AAA-
2 2 Roche Switzerland $7,592M $6,914M AAA- AA+
3 3 Bayer Germany $5,149M $6,209M AA+ AAA-
4 5 Abbott United States $4,572M $4,455M AA AA
5 6 Merck & Co United States $4,296M $4,141M AA AA+
6 4 Pfizer United States $3,814M $4,776M AA AA+
7 8 Celgene United States $3,665M $3,310M AA AA-
8 9 GSK United Kingdom $3,519M $3,286M AA AA
9 7 Sanofi France $3,475M $3,384M AA AA
10 AbbVie United States $3,420M $0M AA
11 10 Novartis Switzerland 🔒 🔒 🔒 🔒
12 AstraZeneca United Kingdom 🔒 🔒 🔒 🔒
13 Bristol-Myers Squibb United States 🔒 🔒 🔒 🔒
14 Eli Lilly and Company United States 🔒 🔒 🔒 🔒
15 Sinopharm China 🔒 🔒 🔒 🔒
16 Takeda Japan 🔒 🔒 🔒 🔒
17 Amgen United States 🔒 🔒 🔒 🔒
18 Novo Nordisk Denmark 🔒 🔒 🔒 🔒
19 Gilead Sciences United States 🔒 🔒 🔒 🔒
20 Biogen United States 🔒 🔒 🔒 🔒
21 Merck KGaA Germany 🔒 🔒 🔒 🔒
22 Alcon United States 🔒 🔒 🔒 🔒
23 Allergan United States 🔒 🔒 🔒 🔒
24 SPH China 🔒 🔒 🔒 🔒
25 Teva Israel 🔒 🔒 🔒 🔒
Loading...